At HKLife, we are focused on developing new technologies and products that enables us to continue innovation, and serving our customers worldwide with biotechnology. We work with each of our customers in understanding their needs and providing the world technology and product-based solutions. Research and development is a vital part invested in HKLife, to bring resources through means of biotechnology that makes a difference.

HKLife is committed to continuously increasing the strength of its patent portfolio, by investing in biotechnology innovation research and development devoted to advancing molecular diagnostic technology and applications, and its EFADchip technology.

HKLife’s patent portfolio currently includes 60 patent granted applications worldwide. The list of issued patents below does not represent the full scope of protection covered by the HKLife patent portfolio.

• A novel DNA chips system and its manufacture
• Apparatus and methods for detecting DNA in biological samples using electrical hybridization
• Apparatus and methods for detecting DNA in biological samples
• Improvement on DNA Chips
• A kit for detecting non-pathogenic or pathogenic influenza A subtype H5 virus
• A kit for detecting avian influenza virus type A subtypes H6, H7, or H9
• A process for detecting nucleic acid target molecules using an enzyme-linked probe capture assay
• A novel DNA extraction method for GMO testing
• A process for detecting foot-and-mouth disease virus